ARCHIVES

FDA Oncologic Drugs Advisory Committee: Trials In A Small Indication Tell Big Story About Pitfalls of Delaying Progression

This article is from The Cancer Letter archive.

Vol. 37 No. 15 | April 15, 2011

Download PDF Visit The Full Archive

Related Articles

AHCPR Funds Centers to Review Practice

July 4, 1997

NCI Programs: Genetic Variations Discovered, Added to NCI Database

June 11, 1999

Amgen, J&J Defend ESA Indications.

March 21, 2008

Phase 1 Study Asked to Determine If Drug Administration Timing Improves Results

April 4, 1986

Greenberg: More Work Needs to be Done

November 7, 2014

Stem Cell Transplant More Effective than Chemotherapy

April 25, 2003